Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth

S. J. Deharvengt, J. R. Gunn, S. B. Pickett, Murray Korc

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of this study was to assess the biological consequences of cyclin D1 silencing in pancreatic cancer cells. A replication-defective lentivirus based small hairpin RNA (shRNA) system targeting cyclin D1 caused a marked reduction in cyclin D1 protein levels in ASPC-1 and BxPC3 pancreatic cancer cell lines in conjunction with decreased cell growth and invasiveness in vitro. Moreover, a single intratumoral injection of the recombinant lentivirus targeting cyclin D1 attenuated the growth of pre-existing tumors arising from two distinct cell lines. This attenuated growth correlated with decreased proliferation and angiogenesis, as well as attenuated vascular endothelial growth factor expression. It is concluded that lentivirus-delivered shRNA targeting cyclin D1 suppresses the growth, invasiveness, tumorigenicity and pro-angiogenic potential of human pancreatic cancer cells, thereby raising the possibility that intratumoral injections of viruses targeting cyclin D1 could provide a new therapeutic approach in pancreatic ductal adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalCancer Gene Therapy
Volume17
Issue number5
DOIs
StatePublished - May 2010
Externally publishedYes

Fingerprint

Cyclin D1
Pancreatic Neoplasms
Small Interfering RNA
Lentivirus
Growth
Cell Line
Injections
Vascular Endothelial Growth Factor A
Adenocarcinoma
Viruses
Neoplasms
Proteins

Keywords

  • Cyclin D1
  • Lentivirus
  • Pancreatic cancer
  • ShRNA

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Molecular Biology

Cite this

Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth. / Deharvengt, S. J.; Gunn, J. R.; Pickett, S. B.; Korc, Murray.

In: Cancer Gene Therapy, Vol. 17, No. 5, 05.2010, p. 325-333.

Research output: Contribution to journalArticle

Deharvengt, S. J. ; Gunn, J. R. ; Pickett, S. B. ; Korc, Murray. / Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth. In: Cancer Gene Therapy. 2010 ; Vol. 17, No. 5. pp. 325-333.
@article{758daa319d804a94a90db64daf19b8ed,
title = "Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth",
abstract = "The aim of this study was to assess the biological consequences of cyclin D1 silencing in pancreatic cancer cells. A replication-defective lentivirus based small hairpin RNA (shRNA) system targeting cyclin D1 caused a marked reduction in cyclin D1 protein levels in ASPC-1 and BxPC3 pancreatic cancer cell lines in conjunction with decreased cell growth and invasiveness in vitro. Moreover, a single intratumoral injection of the recombinant lentivirus targeting cyclin D1 attenuated the growth of pre-existing tumors arising from two distinct cell lines. This attenuated growth correlated with decreased proliferation and angiogenesis, as well as attenuated vascular endothelial growth factor expression. It is concluded that lentivirus-delivered shRNA targeting cyclin D1 suppresses the growth, invasiveness, tumorigenicity and pro-angiogenic potential of human pancreatic cancer cells, thereby raising the possibility that intratumoral injections of viruses targeting cyclin D1 could provide a new therapeutic approach in pancreatic ductal adenocarcinoma.",
keywords = "Cyclin D1, Lentivirus, Pancreatic cancer, ShRNA",
author = "Deharvengt, {S. J.} and Gunn, {J. R.} and Pickett, {S. B.} and Murray Korc",
year = "2010",
month = "5",
doi = "10.1038/cgt.2009.75",
language = "English (US)",
volume = "17",
pages = "325--333",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth

AU - Deharvengt, S. J.

AU - Gunn, J. R.

AU - Pickett, S. B.

AU - Korc, Murray

PY - 2010/5

Y1 - 2010/5

N2 - The aim of this study was to assess the biological consequences of cyclin D1 silencing in pancreatic cancer cells. A replication-defective lentivirus based small hairpin RNA (shRNA) system targeting cyclin D1 caused a marked reduction in cyclin D1 protein levels in ASPC-1 and BxPC3 pancreatic cancer cell lines in conjunction with decreased cell growth and invasiveness in vitro. Moreover, a single intratumoral injection of the recombinant lentivirus targeting cyclin D1 attenuated the growth of pre-existing tumors arising from two distinct cell lines. This attenuated growth correlated with decreased proliferation and angiogenesis, as well as attenuated vascular endothelial growth factor expression. It is concluded that lentivirus-delivered shRNA targeting cyclin D1 suppresses the growth, invasiveness, tumorigenicity and pro-angiogenic potential of human pancreatic cancer cells, thereby raising the possibility that intratumoral injections of viruses targeting cyclin D1 could provide a new therapeutic approach in pancreatic ductal adenocarcinoma.

AB - The aim of this study was to assess the biological consequences of cyclin D1 silencing in pancreatic cancer cells. A replication-defective lentivirus based small hairpin RNA (shRNA) system targeting cyclin D1 caused a marked reduction in cyclin D1 protein levels in ASPC-1 and BxPC3 pancreatic cancer cell lines in conjunction with decreased cell growth and invasiveness in vitro. Moreover, a single intratumoral injection of the recombinant lentivirus targeting cyclin D1 attenuated the growth of pre-existing tumors arising from two distinct cell lines. This attenuated growth correlated with decreased proliferation and angiogenesis, as well as attenuated vascular endothelial growth factor expression. It is concluded that lentivirus-delivered shRNA targeting cyclin D1 suppresses the growth, invasiveness, tumorigenicity and pro-angiogenic potential of human pancreatic cancer cells, thereby raising the possibility that intratumoral injections of viruses targeting cyclin D1 could provide a new therapeutic approach in pancreatic ductal adenocarcinoma.

KW - Cyclin D1

KW - Lentivirus

KW - Pancreatic cancer

KW - ShRNA

UR - http://www.scopus.com/inward/record.url?scp=77951112296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951112296&partnerID=8YFLogxK

U2 - 10.1038/cgt.2009.75

DO - 10.1038/cgt.2009.75

M3 - Article

VL - 17

SP - 325

EP - 333

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 5

ER -